Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

Item
http://www.wikidata.org/entity/Q27851584
CIViC databaseA systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma.Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of actionThree-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma.The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagusPrognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.Esophageal carcinoma cell line with high EGFR polysomy is responsive to gefitinib.Subcellular localization of EGFR in esophageal carcinoma cell lines.Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.Clinicopathological and prognostic significance of epidermal growth factor receptor overexpression in patients with esophageal adenocarcinoma: a meta-analysis.Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis.A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
P2860

Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

Item
http://www.wikidata.org/entity/Q27851584
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@ast
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@en
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@nl
type
label
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@ast
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@en
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@nl
prefLabel
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@ast
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@en
Homogeneous EGFR amplification ...... arcinomas with poor prognosis.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Homogeneous EGFR amplification ...... carcinomas with poor prognosis
@en
P2093
P304
P31
P356
10.1111/J.1365-2559.2010.03643.X
P433
P478
P50
P577
P698
P921